Oxford-Harrington Rare Disease Centre

The Oxford-Harrington Rare Disease Centre (OHC) is a partnership between the University of Oxford (UK) and Harrington Discovery Institute at University Hospitals in Cleveland (OH, USA) with a mission deliver new treatments and cures for the approximately 500 million people affected by rare diseases worldwide.

The OHC’s guiding vision is to advance 40 new medicines into clinical development by 2034, leveraging powerful new scientific technologies, and with a focus on genetic diseases.